Aquatic Capital Management’s Novo Nordisk NVO Stock Holding History

Aquatic Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-303,448	Closed	-$16.8M	–	1649
2025 Q3	$16.8M	Buy	+303,448	New	+$17.8M	0.31%	79
2025 Q2	–	Sell	-118,463	Closed	-$8.23M	–	1449
2025 Q1	$8.23M	Buy	+118,463	New	+$9.78M	0.21%	124
2024 Q3	–	Sell	-9,400	Closed	-$1.34M	–	1415
2024 Q2	$1.34M	Buy	9,400 +3,400	+57%	+$451K	0.05%	338
2024 Q1	$770K	Sell	6,000 -99,000	-94%	-$11.8M	0.03%	444
2023 Q4	$10.9M	Buy	+105,000	New	+$10.4M	0.28%	94
2023 Q3	–	Sell	-61,800	Closed	-$5M	–	1523
2023 Q2	$5M	Buy	+61,800	New	+$5.05M	0.27%	90
2022 Q4	–	Sell	-19,200	Closed	-$956K	–	1677
2022 Q3	$956K	Buy	19,200 +13,000	+210%	+$696K	0.09%	271
2022 Q2	$345K	Buy	+6,200	New	+$344K	0.11%	219

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aquatic Capital Management's NVO Position: Q4 2025 in Review

Aquatic Capital Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 303,448 shares — an estimated $16.8M sold.

Aquatic Capital Management first reported a position in NVO in Q2 2022 and held it in 8 quarters. The position peaked at $16.8M in Q3 2025. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

Aquatic Capital Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
Aquatic Capital Management sold 303,448 Novo Nordisk shares in Q4 2025, an estimated $16.8M.
Aquatic Capital Management first reported a position in Novo Nordisk in Q2 2022 and held it in 8 quarters.
Aquatic Capital Management's Novo Nordisk position peaked at $16.8M in Q3 2025.
1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Aquatic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.